NCT07490353: Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects
- State
- Under way
- Phase
- Phase 1
- People
- 85 planned
- Started
- 1 Nov 2025
- Primary completion
- 31 May 2028
- Arms
- Psilocybin first, psilocybin + risperidone second, Psilocybin + risperidone first, psilocybin second
- Results
- None posted
- 1 Nov 2025: Trial started
- 24 Mar 2026: Trial registered